Hirokazu Tanaka - Concepedia

Author

Hirokazu Tanaka

Also Known As

H TANAKA, H Tanaka, H. TANAKA, H. Tanaka, HIROKAZU TANAKA, Hidetake Tanaka, Hirokazu TANAKA, Hirokazu Tanaka, Hirokazu Tanaka (332056), Hironao TANAKA

242

Publications

Citations

H-Index

122

Concepts

All Affiliations

Fujisawa City Hospital Mochida Pharmaceutical (Japan)National Defense Academy of Japan Hokkaido University

About

Hirokazu Tanaka is an author at Fujisawa City Hospital specializing in pharmacology, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	22	1.3K
2	Natural Sciences	17	29	804
3	Engineering	12	15	351
4	Education	1	1	33
5	Health Sciences	1	1	91

Hirokazu Tanaka

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Structure of FK506, a novel immunosuppressant isolated from Streptomyces Hirokazu Tanaka, Akio Kuroda, Hiroshi Marusawa, Journal of the American Chemical Society Molecular PharmacologyNovel ImmunosuppressantBiochemistryDonut IconMedicine	1987	514
In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi Shuichi Tawara, Fumiaki Ikeda, Katsuyuki Maki, Antimicrobial Agents and Chemotherapy	2000	310
FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. II. Structure determination. Nobuharu Shigematsu, Hirotsugu Ueda, Shigehiro Takase, The Journal of Antibiotics	1994	131
Discovery of the First Non-Peptide Full Agonists for the Human Bradykinin B<sub>2</sub>Receptor Incorporating 4-(2-Picolyloxy)quinoline and 1-(2-Picolyl)benzimidazole Frameworks Yuki Sawada, Hiroshi Kayakiri, Yoshito Abe, Journal of Medicinal Chemistry	2004	113
FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. II. Fermentation, isolation and physico-chemical and biological characteristics. HIROSHI HATANAKA, TOHRU KINO, Susumu Miyata, The Journal of Antibiotics	1988	109
Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes : Up-regulation of TNF, IFN-γ and IL-2, in contrast to down-regulation of IL-6 production Izumi Tsuboi, Izumi Tsuboi, Hirokazu Tanaka, Cytokine InflammationCytokine ProductionNonsteroidal Anti-inflammatory DrugsCytokineImmune Cell Development	1995	95
Chronic Intracerebroventricular Administration of Relaxin-3 Increases Body Weight in Rats Takayuki Hida, Eiki Takahashi, Kodo Shikata, Journal of Receptors and Signal Transduction Locomotor ActivityExperimental PharmacologyNeuromuscular BlockadeGastrointestinal Peptide HormoneIntegrative Physiology	2006	91
A Novel Class of Orally Active Non-Peptide Bradykinin B<sub>2</sub> Receptor Antagonists. 1. Construction of the Basic Framework Yoshito Abe, Hiroshi Kayakiri, Shigeki Satoh, Journal of Medicinal Chemistry Combinatorial ChemistryNew SeriesChemical BiologyPharmaceutical ChemistryMolecular Pharmacology	1998	91
New Antitumor Substances, FR901463, FR901464 and FR901465. III. Structures of FR901463, FR901464 and FR901465. Hidenori Nakajima, Shigehiro Takase, Hiroshi Terano, The Journal of Antibiotics	1997	87
Studies on WF-3161, a new antitumor antibiotic. KAZUYOSHI UMEHARA, Kunio Nakahara, SUMIO KIYOTO, The Journal of Antibiotics	1983	84

Page 1